One of the better charts I was able to find while doing my weekend screening. Apparently, the company announced that its inhibitor-tolerant qPCR master mixes are ideal for the development of fast, accurate and highly sensitive qPCR monkeypox virus (monkeypox) molecular diagnostic tests. If (and I hope not) monkeypox does become a thing, we might see a turn in VIVO's fundamentals which would be conducive for share price appreciation. In fact, they have most recently announced a double beat in their quarterly earnings - a potential sign!
Technically, I like the basing action on this chart. There are clear signs of accumulation coupled with VIVO holding up super well as the major market indices look ugly. Will be keeping this on a close watch this week and am not afraid to buy if we break out of the pivot point on high volume. Still contemplating if I should set my stop loss at $28 (just below price consolidation in the 30min chart) or lower than that, will decide when the time comes!
This is not financial advice, just journaling my thoughts as I look through charts to gauge the health of the market.
Technically, I like the basing action on this chart. There are clear signs of accumulation coupled with VIVO holding up super well as the major market indices look ugly. Will be keeping this on a close watch this week and am not afraid to buy if we break out of the pivot point on high volume. Still contemplating if I should set my stop loss at $28 (just below price consolidation in the 30min chart) or lower than that, will decide when the time comes!
This is not financial advice, just journaling my thoughts as I look through charts to gauge the health of the market.